The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Self-citationA Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
Julius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G., Klinger, G. H., Neaton, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,961
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Dickstein, K., & Kjekshus, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09895-1 · Cited by 1,203
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
Lindholm, L. H., Carlberg, B., & Samuelsson, O. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67573-3 · Cited by 999
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Goldman, L., Hashimoto, B., Cook, E. F., & Loscalzo, A. (1981) · Circulation · doi:10.1161/01.cir.64.6.1227 · Cited by 978
THE CELLULAR AND MOLECULAR RESPONSE OF CARDIAC MYOCYTES TO MECHANICAL STRESS
Sadoshima, J., & Izumo, S. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.551 · Cited by 864
Viberti, G., & Wheeldon, N. M. (2002) · Circulation · doi:10.1161/01.cir.0000024416.33113.0a · Cited by 802
Schrader, J., Lüders, S., Kulschewski, A., Hammersen, F., Plate, K., Berger, J., Zidek, W., Dominiak, P., Diener, H. C., & the MOSES Study Group (2005) · Stroke · doi:10.1161/01.str.0000166048.35740.a9 · Cited by 766
Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
Hansson, L., Hedner, T., & Dahlöf, B. (1992) · Blood Pressure · doi:10.3109/08037059209077502 · Cited by 577
Self-citationStaessen, J. A., Wang, J.-G., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00002 · Cited by 487
Kubo, M., Kiyohara, Y., Kato, I., Tanizaki, Y., Arima, H., Tanaka, K., Nakamura, H., Okubo, K., & Iida, M. (2003) · Stroke · doi:10.1161/01.str.0000090348.52943.a2 · Cited by 401
Bonow, R. O., Smaha, L. A., Smith, S. C., Mensah, G. A., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000035036.22612.2b · Cited by 353
Dzau, V., & Braunwald, E. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90694-d · Cited by 322
[The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)].
Saruta, T. (2005) · PubMed · Cited by 259
Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)
Japanese Society of Hypertension (2006) · Hypertension Research · doi:10.1291/hypres.29.s1 · Cited by 216
The cardiovascular continuum and renin–angiotensin–aldosterone system blockade
Dzau, V. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000165623.72310.dd · Cited by 207
Pfeffer, M. A., McMurray, J. J. V., & Velazquez, E. J. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.12.039 · Cited by 147
Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J., & Asada, A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.051 · Cited by 106
Effects of Candesartan on Cardiovascular Outcomes in Japanese Hypertensive Patients
Suzuki, H., & Kanno, Y. (2005) · Hypertension Research · doi:10.1291/hypres.28.307 · Cited by 85
Demographic Study of First-ever Stroke and Acute Myocardial Infarction in Okinawa, Japan.
Kimura, Y., Takishita, S., Muratani, H., Kinjo, K., Shinzato, Y., Muratani, A., & Fukiyama, K. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.736 · Cited by 76
MUNAKATA, M., Nagasaki, A., Nunokawa, T., Sakuma, T., KATO, H., YOSHINAGA, K., & Toyota, T. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.028 · Cited by 73
Brunner, H. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01538-7 · Cited by 70
Kasama, S., Toyama, T., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., & Kurabayashi, M. (2003) · PubMed · Cited by 63
Valsartan Decreases Type I Collagen Synthesis in Patients With Hypertrophic Cardiomyopathy
Kawano, H., Toda, G., 中溝, 礼., Koide, Y., Seto, S., & Yano, K. (2005) · Circulation Journal · doi:10.1253/circj.69.1244 · Cited by 59
Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy
Suzuki, K., Souda, S., Ikarashi, T., et al. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00098-0 · Cited by 19
Mochizuki, S., Shimizu, M., Taniguchi, I., Kanae, K., Yoshida, S., Tajima, N., & Dahlöf, B. (2004) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000041250.00079.84 · Cited by 15
Self-citation
Cited by
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,289
Isselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001106 · Cited by 2,082
Metadata
- Authors
- Mochizuki, S., Dahlöf, B., Shimizu, M., Ikewaki, K., Yoshikawa, M., Taniguchi, I., Ohta, M., Yamada, T., Ogawa, K., Kanae, K., Kawai, M., Seki, S., Okazaki, F., Taniguchi, M., Yoshida, S., & Tajima, N.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 369
- Issue
- 9571
- Pages
- 1431-1439
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2160654062
- Cited by
- 347
- References
- 37
- FWCI
- 36.72
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.